Monogenic gene therapy for glaucoma and optic nerve injury

作     者：Chikako Harada Xiaoli Guo Takayuki Harada Chikako Harada;Xiaoli Guo;Takayuki Harada

作者机构：Visual Research ProjectTokyo Metropolitan Institute of Medical ScienceTokyoJapan 

出 版 物：《Neural Regeneration Research》 (中国神经再生研究（英文版）)

年 卷 期：2025年第20卷第3期

页      面：815-816页

核心收录：

学科分类：1002[医学-临床医学] 1010[医学-医学技术（可授医学、理学学位）] 100212[医学-眼科学] 100215[医学-康复医学与理疗学] 10[医学] 

基　　金：supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-Aid for Scientific Research (JP22K09804 to CH JP21K09688 to XG JP19KK0229, JP21H04786, JP21H02819 and JP21K18279 to TH) the Shiseido Female Researcher Science Grant (to XG) Mitsubishi Foundation Takeda Science Foundation (to TH) 

主　　题：visual glaucoma degeneration 

摘      要：The prevalence of glaucoma, the second leading cause of global blindness, is increasing due to aging populations. In glaucoma, degeneration of the optic nerve and retinal ganglion cells(RGCs) causes visual field defects and eventual blindness.